Antimicrobial office acting director
Executive Summary
CDER Office of Antimicrobial Drug Products Deputy Director Edward Cox is named acting director effective Aug. 21. Former director Mark Goldberger recently accepted a position in CBER as medical director for emerging and pandemic threat preparedness effective Aug. 20 (1"The Pink Sheet" July 24, 2006, In Brief). Division of Antiviral Drug Products Deputy Director Jeff Murray will serve as acting deputy director of OAP...
You may also be interested in...
...And with FDA
Former Center for Drug Evaluation & Research Office of Antimicrobial Products Director Mark Goldberger is appointed to the newly created position of Emergency & Pandemic Threat Preparedness Medical Director in the Center for Biologics Evaluation & Research, where he will guide development and evaluation of products related to pandemic threats...
GeNeuro To Tackle Long COVID By Targeting Ancestor Viral Gene Activation
Switzerland’s GeNeuro will study whether its monoclonal antibody temelimab can prevent long-COVID, after data for the first time linked activation of human endogenous retroviruses (HERVs) to the condition and its associated neurological symptoms.
Executives On The Move: CFO Promoted At Novavax, Gilead Gets New Executive Vice President Of Research
Alpha Cognition, F2G and Immune Pharmaceuticals pick up new CEOs, and there is a new chief medical officer at Gemini Therapeutics.